Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.
about
The Vpr protein from HIV-1: distinct roles along the viral life cycleAnalysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiaeStructure of human immunodeficiency virus type 1 Vpr(34-51) peptide in micelle containing aqueous solutionCharacterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assayThe inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90HIV-1 Vpr oligomerization but not that of Gag directs the interaction between Vpr and Gag.Development of a robust cell-based high-throughput screening assay to identify targets of HIV-1 viral protein R dimerization.HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic interventionA comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopesHIV-1 Vpr-a still "enigmatic multitasker".HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies.Proline 35 of human immunodeficiency virus type 1 (HIV-1) Vpr regulates the integrity of the N-terminal helix and the incorporation of Vpr into virus particles and supports the replication of R5-tropic HIV-1 in human lymphoid tissue ex vivo.Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.Direct Vpr-Vpr interaction in cells monitored by two photon fluorescence correlation spectroscopy and fluorescence lifetime imaging.Structural characterization of the HIV-1 Vpr N terminus: evidence of cis/trans-proline isomerism.
P2860
Q21245211-79AD2BC6-0456-4A2C-B699-D479BE288651Q24804945-9138588E-B7A6-4B39-9ED9-80A4FC8ACA2FQ27639255-7C8DA140-A682-477F-80C3-6FB3F432931FQ28477791-37884473-9BDD-4AC3-AFFE-E660E3823F3BQ30440445-344146A6-3D20-4B65-B1DD-F42C587437D6Q33466002-7490AABC-1AC1-47B6-9A9F-0D24E95A47F4Q33614489-31C0E05D-18A5-4D1F-B2B2-BB7CB63B0CEFQ34758051-D8DD49A6-61E7-48E6-90DF-99B7B6013FA3Q34957142-CF73BD72-6339-46A9-9FA6-F4CFF7599401Q36908259-BD3126C1-2E54-45B2-B1CC-21A322949CBCQ37689513-234917FF-CDCB-47CB-95D8-A8EF5CD5D521Q38855423-971382EB-28F8-4A87-8EE5-634776CB6551Q39565551-286B109A-5D25-4DAE-94D3-CFF42B8E2166Q39696115-D6EAFBD8-6B37-45FC-865D-F107AFC586E2Q40618199-8C7EA5C6-7B56-4D5E-8A3B-6D074ADFA7B5Q43132065-A8350756-7F6A-463C-A817-3129B0C42874Q44526083-4D4456E3-F275-4856-A3C9-8E919CCE9379
P2860
Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Functional role of residues co ...... nodeficiency virus type 1 Vpr.
@ast
Functional role of residues co ...... nodeficiency virus type 1 Vpr.
@en
type
label
Functional role of residues co ...... nodeficiency virus type 1 Vpr.
@ast
Functional role of residues co ...... nodeficiency virus type 1 Vpr.
@en
prefLabel
Functional role of residues co ...... nodeficiency virus type 1 Vpr.
@ast
Functional role of residues co ...... nodeficiency virus type 1 Vpr.
@en
P2093
P2860
P1433
P1476
Functional role of residues co ...... nodeficiency virus type 1 Vpr.
@en
P2093
A Srinivasan
B Tomkowicz
S Mahalingam
V S Kalyanaraman
P2860
P304
10650-10657
P356
10.1128/JVI.74.22.10650-10657.2000
P577
2000-11-01T00:00:00Z